(Total Views: 369)
Posted On: 05/10/2019 5:08:51 PM
Post# of 149332
Thanks for sharing! Interesting and had some new info.
1) mono pivotal trial 48 weeks and estimated approval around 2021
2) initiating NASH preclinical trial (most small NASH companies have $1B MC)
3) interim clinical TNBC results 4-5 months
4) BLA submission July-Oct (thought this may move up with the 525 results, but instead added a month to the worst case)
5) NP going to S Korea and potential to increase deal to $10B eventually ($250M I understood as costs which would be 2.5% likely at $120k price tag).
I’ll listen again, but this was my initial takeaway.
1) mono pivotal trial 48 weeks and estimated approval around 2021
2) initiating NASH preclinical trial (most small NASH companies have $1B MC)
3) interim clinical TNBC results 4-5 months
4) BLA submission July-Oct (thought this may move up with the 525 results, but instead added a month to the worst case)
5) NP going to S Korea and potential to increase deal to $10B eventually ($250M I understood as costs which would be 2.5% likely at $120k price tag).
I’ll listen again, but this was my initial takeaway.
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
